Sacubitrilcalcium , ≥98%(HPLC) , 1369773-39-6

Synonym(s):
(2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic acid ethyl ester;4-[[(2S,4R)-5-Ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoic acid calcium salt;4-{[(2S,4R)-1-(4-Biphenylyl)-5-ethoxy-4-methyl-5-oxo-2-pentanyl]amino}-4-oxobutanoic acid; (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester;AHU377 calcium salt;AHU-377 calcium salt

CAS NO.：1369773-39-6

Empirical Formula: C48H56CaN2O10

Molecular Weight: 861.044

MDL number: MFCD28137893

Pack Size	Price	Stock	Quantity
5mg	RMB68.00	In Stock
10mg	RMB95.20	In Stock
25mg	RMB159.20	In Stock
50mg	RMB231.20	In Stock
100mg	RMB319.20	In Stock
250mg	RMB559.20	In Stock
1g	RMB1599.20	In Stock
5g	RMB5599.20	In Stock
others			Enquire

Update time: 2022-07-08

PRODUCT Properties

Melting point:	>140°C (dec.)
Density	1.24g/cm3 at 20℃
vapor pressure	0.001Pa at 20℃
storage temp.	-20°C
solubility	DMSO (Slightly, Heated), Methanol (Slightly)
form	powder
color	white to beige
LogP	-0.66-2.9 at 20℃ and pH2-7

Description and Uses

Sacubitril is an antihypertensive drug used in combination with valsartan. The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure.

Safety

Symbol(GHS)	GHS06,GHS09
Signal word	Danger
Hazard statements	H301-H400
Precautionary statements	P273-P301+P310+P330
RIDADR	UN2811 - class 6.1 - PG 3 - EHS - Toxic solids, organic, n.o.s., HI: all

RELATED PRODUCTS

(R)-Ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate
149709-59-1

(2R,4S)-Ethyl5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoatehydrochloride
149690-12-0

(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid
1012341-50-2

Valsartan
137862-53-4

(S)-5-[(Biphenyl-4-yl)methyl]pyrrolidin-2-one
1038924-61-6